Key result
Moderate hyperhomocysteinemia linked to ~4.4-fold higher odds of ischemic stroke in children.
Case-Control (n=279)
Answers are grounded in this paper and cite their sources.
Case-control study reveals moderate hyperhomocysteinemia is associated with ischemic stroke in children, indicating an elevated vascular risk.
BACKGROUND: Moderate hyperhomocysteinemia is a risk factor for arterial vascular disease and venous thrombosis in adults. We performed a case-control study to assess a possible relation between moderate hyperhomocysteinemia and ischemic stroke in Dutch children (age range, 0 to 18 years). METHODS AND RESULTS: We measured plasma total homocysteine levels (tHcy) in 45 patients with ischemic stroke and in 234 controls. Hyperhomocysteinemia was defined as a tHcy above the 95th percentile regression line for the respective age of the controls. Hyperhomocysteinemia was present in 8 (18%) of the 45 patients with ischemic stroke. The odds ratio was 4.4 (95% CI, 1.7 to 11.6). CONCLUSIONS: We conclude that moderate hyperhomocysteinemia is a risk factor for ischemic stroke in children.
No takes yet. Share an insight, caveat, or question.
Beynum et al. (1999) conducted a case-control in Ischemic stroke (n=279). Moderate hyperhomocysteinemia (tHcy above the 95th percentile regression line for age) vs. Normal plasma total homocysteine levels was evaluated on Ischemic stroke (OR 4.4, 95% CI 1.7 to 11.6). Moderate hyperhomocysteinemia was present in 18% of children with ischemic stroke and increased stroke odds.
Synapse has enriched 10 related papers. Consider them for comparative context: